ThomasPatrickHavertyMD

PubMed

• 81 citations
  Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti–IL-5 antibody SCH55700
  Yae-Jean Kim, Calman Prussin, Brian Martin, Melissa A. Law, Thomas P. Haverty, Thomas B. Nutman, Amy D. Klion> ;The Journal of Allergy and Clinical Immunology. 2004 Dec 1
• 122 citations
  Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome.
  Amy D. Klion, Melissa A. Law, Pierre Noel, Yae Jean Kim, Thomas P. Haverty, Thomas B. Nutman> ;Blood. 2004 Apr 15
• 38 citations
  Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody t...
  Hendrik Schulze-Koops, Laurie S. Davis, Thomas P. Haverty, Mary C. Wacholtz, Peter E. Lipsky> ;The Journal of Rheumatology. 1998 Nov 1
• 22 citations
  Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis
  Larry W. Moreland, Thomas P. Haverty, Wacholtz Mc, Knowles Rw, R. P. Bucy, Louis W. Heck, William J. Koopman> ;The Journal of Rheumatology. 1998 Feb 1
• 39 citations
  Treatment of Recalcitrant Plaque Psoriasis with a Humanized Non-depleting Antibody to CD4
  Hervé Bachelez, Béatrice Flageul, Louis Dubertret, Sylvie Fraitag, R. Grossman, Nicole Brousse, Dominique Poisson, R. W. Knowles, Mary C. Wacholtz, Thomas P. Haverty, ...> ;Journal of Autoimmunity. 1998 Feb 1
• 36 citations
  OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: Association with improvement in long-term survival
  Daniel Abramowicz, Douglas J. Norman, Pierre Vereerstraeten, Michel Goldman, Luc De Pauw, Jean-Louis Vanherweghem, Paul Kinnaert, Lawrence Kahana, Frank P. Stuart, J. ...> ;Kidney International. 1996 Mar 1
• 18 citations
  Characterization of a cis-acting regulatory element which silences expression of the class II-A beta gene in epithelium.
  Shelley E. Albert, Frank Strutz, Kathleen Shelton, Thomas P. Haverty, Mae Jane Sun, Shao Ran Li, Amy Denham, Richard A. Maki, Eric G. Neilson> ;The Journal of Experimental Medicine. 1994 Jul 1
• 98 citations
  A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.
  Douglas J. Norman, Lawrence Kahana, Frank P. Stuart, J. R. Thistlethwaite, Charles F. Shield, Anthony P. Monaco, Jennifer Dehlinger, Shu Chen Wu, Allan Van Horn, Thoma...> ;Transplantation. 1993 Jan 1
• 24 citations
  Role of insulin and IGF1 receptors in proliferation of cultured renal proximal tubule cells.
  Bonnie L. Blazer-Yost, Melanie Watanabe, Thomas P. Haverty, Fuad N. Ziyadeh> ;Biochimica Et Biophysica Acta. 1992 Feb 3
• 6 citations
  Tubular antigen-binding proteins repress transcription of type IV collagen in the autoimmune target epithelium of experimental interstitial nephritis.
  Thomas P. Haverty, Carolyn J. Kelly, John R. Hoyer, Rene Alvarez, Eric G. Neilson> ;The Journal of Clinical Investigation. 1992 Feb 1
• 99 citations
  Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines.
  Rene Alvarez, Mae Jane Sun, Thomas P. Haverty, Renato V. Iozzo, Jeanne C. Myers, Eric G. Neilson> ;Kidney International. 1992 Jan 1
• 246 citations
  Mechanisms of tubulointerstitial fibrosis.
  Gerald S. Kuncio, Eric G. Neilson, Thomas P. Haverty> ;Kidney International. 1991 Mar 1
• 29 citations
  Molecular characterization of a major nephritogenic domain in the autoantigen of anti-tubular basement membrane disease.
  Eric G. Neilson, Mae Jane Sun, Carolyn J. Kelly, William H. Hines, Thomas P. Haverty, M D Clayman, Nancy E. Cooke> ;Proceedings of the National Academy of Sciences of the United States of America. 1991 Mar 1
• 162 citations
  High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule
  Fuad N. Ziyadeh, Edward R. Snipes, Melanie Watanabe, R. Alvarez, Stanley Goldfarb, Thomas P. Haverty> ;The American Journal of Physiology. 1990 Oct 1
• 26 citations
  Protective modulation of class II MHC gene expression in tubular epithelium by target antigen-specific antibodies. Cell-surface directed down-regulation of transcripti...
  Thomas P. Haverty, Melanie Watanabe, Eric G. Neilson, Carolyn J. Kelly> ;Journal of Immunology. 1989 Aug 15
• 19 citations
  T cell recognition of epithelial self.
  William H. Hines, Thomas P. Haverty, Jack A. Elias, Eric G. Neilson, Carolyn J. Kelly> ;Autoimmunity. 1989 Jan 1
• 279 citations
  Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis
  Thomas P. Haverty, Carolyn J. Kelly, William H. Hines, Peter S. Amenta, Melanie Watanabe, Robert A. Harper, Nicholas A. Kefalides, Eric G. Neilson> ;The Journal of Cell Biology. 1988 Oct 1
• 13 citations
  Basement membrane gene expression in polycystic kidney disease.
  Thomas P. Haverty, Eric G. Neilson> ;Laboratory Investigation; a Journal of Technical Methods and Pathology. 1988 Jan 1
• 12 citations
  Murine interstitial nephritis. VII. Suppression of renal injury after treatment with soluble suppressor factor TsF1.
  Eric G. Neilson, Carolyn J. Kelly, M D Clayman, William H. Hines, Thomas P. Haverty, Mae Jane Sun, N Blanchard> ;Journal of Immunology. 1987 Sep 1
• 5 citations
  1,25-Dihydroxyvitamin D3 stimulates interleukin-2 production by a T cell lymphoma line (MLA-144) cultured in vitamin D-deficient rat serum
  Thomas P. Haverty, John G. Haddad, Eric G. Neilson> ;Journal of Leukocyte Biology. 1987 Feb 1
• 10 citations
  Experimental strategies for the study of cellular immunity in renal disease.
  Eric G. Neilson, M D Clayman, Thomas P. Haverty, Carolyn J. Kelly, Richard Mann> ;Kidney International. 1986 Aug 1
• 34 citations
  Spontaneous interstitial nephritis in kdkd mice. II. Characterization of a tubular antigen-specific, H-2K-restricted Lyt-2+ effector T cell that mediates destructive t...
  Carolyn J. Kelly, Robert Korngold, Richard Mann, M D Clayman, Thomas P. Haverty, Eric G. Neilson> ;Journal of Immunology. 1986 Jan 1
• Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.
  Woodle, E. S., Xu, D., Zivin, R. A., Auger, J., Charette, J., O'Laughlin, R., Peace, D., Jollife, L. K., Haverty, T., Bluestone, J. A., Thistlethwaite, J. R.> ;Transplantation. 1999 Sep 15
• Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4.
  Richards, J., Auger, J., Peace, D., Gale, D., Michel, J., Koons, A., Haverty, T., Zivin, R., Jolliffe, L., Bluestone, J. A.> ;Cancer Res. 1999 May 1
• OKT3 treatment of cardiac allograft rejection.
  Haverty, T. P., Sanders, M., Sheahan, M.> ;J Heart Lung Transplant. 1993 Jul 01
• Join now to see all